The U. S. Food and Drug Administration (FDA) has approved Humira for the treatment of moderate to severe Crohn's disease. The FDA estimates that about 1 million Americans suffer from Crohn's disease. Humira has been shown to treat the symptoms of Crohn's and to induce clinical remission in some patients.
Read moreDr. Eisner answers questions about the causes of IBD, treating Crohn's with Tysabri, and surgery for Ulcerative Colitis. If you are... Read more »
A scientific committee has recommended that the European Medicines Agency approve Humira for the treatment of Crohn's disease. Experts say the... Read more »
Researchers have found that people who have moderate to severe ileocolonic Crohn's disease and are treated with a maintenance therapy of Humira... Read more »
According to a new study, about half of patients with moderate to severe Crohn's disease in the trial who took Humira (adalimumab) and responded well... Read more »
Source: First DataBank
Generic Name: ADALIMUMAB - INJECTION Pronounced: (a-da-LIM-ue-mab) Warning This medication can decrease your immune system's ability to fight... Read more »
Drugmaker Abbott has applied to the Food and Drug Administration for approval to use Humira for the treatment of moderate to severe Crohn's disease.... Read more »